"ixekizumab" meaning in All languages combined

See ixekizumab on Wiktionary

Noun [English]

Etymology: From [Term?] + -ki- (“interleukin”) + -zumab (“humanized monoclonal antibody”). Etymology templates: {{af|en||-ki-|-zumab|t2=interleukin|t3=humanized monoclonal antibody}} [Term?] + -ki- (“interleukin”) + -zumab (“humanized monoclonal antibody”) Head templates: {{en-noun|-}} ixekizumab (uncountable)
  1. (pharmacology) A humanized monoclonal antibody for the treatment of autoimmune diseases. It works by binding to interleukin 17 and blocking its action. Wikipedia link: ixekizumab Tags: uncountable Categories (topical): Pharmaceutical drugs

Download JSON data for ixekizumab meaning in All languages combined (2.2kB)

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "",
        "3": "-ki-",
        "4": "-zumab",
        "t2": "interleukin",
        "t3": "humanized monoclonal antibody"
      },
      "expansion": "[Term?] + -ki- (“interleukin”) + -zumab (“humanized monoclonal antibody”)",
      "name": "af"
    }
  ],
  "etymology_text": "From [Term?] + -ki- (“interleukin”) + -zumab (“humanized monoclonal antibody”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "ixekizumab (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms interfixed with -ki-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms suffixed with -zumab",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical drugs",
          "orig": "en:Pharmaceutical drugs",
          "parents": [
            "Drugs",
            "Matter",
            "Pharmacology",
            "Chemistry",
            "Nature",
            "Biochemistry",
            "Medicine",
            "Sciences",
            "All topics",
            "Biology",
            "Fundamental"
          ],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "2015 December 12, “Evolution of Cooperation Patterns in Psoriasis Research: Co-Authorship Network Analysis of Papers in Medline (1942–2013)”, in PLOS ONE, →DOI",
          "text": "More recently, other biological drugs, such as ustekinumab, ixekizumab, tofacitinib, secukinumab and briakinumab, have targeted immunological mediators of the disease.",
          "type": "quotation"
        }
      ],
      "glosses": [
        "A humanized monoclonal antibody for the treatment of autoimmune diseases. It works by binding to interleukin 17 and blocking its action."
      ],
      "id": "en-ixekizumab-en-noun-jQEuCzK3",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "humanized",
          "humanized"
        ],
        [
          "monoclonal antibody",
          "monoclonal antibody"
        ],
        [
          "autoimmune",
          "autoimmune"
        ],
        [
          "disease",
          "disease"
        ],
        [
          "interleukin",
          "interleukin"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A humanized monoclonal antibody for the treatment of autoimmune diseases. It works by binding to interleukin 17 and blocking its action."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "ixekizumab"
      ]
    }
  ],
  "word": "ixekizumab"
}
{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "",
        "3": "-ki-",
        "4": "-zumab",
        "t2": "interleukin",
        "t3": "humanized monoclonal antibody"
      },
      "expansion": "[Term?] + -ki- (“interleukin”) + -zumab (“humanized monoclonal antibody”)",
      "name": "af"
    }
  ],
  "etymology_text": "From [Term?] + -ki- (“interleukin”) + -zumab (“humanized monoclonal antibody”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "ixekizumab (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English entries with incorrect language header",
        "English lemmas",
        "English nouns",
        "English term requests",
        "English terms interfixed with -ki-",
        "English terms suffixed with -zumab",
        "English terms with quotations",
        "English uncountable nouns",
        "en:Pharmaceutical drugs"
      ],
      "examples": [
        {
          "ref": "2015 December 12, “Evolution of Cooperation Patterns in Psoriasis Research: Co-Authorship Network Analysis of Papers in Medline (1942–2013)”, in PLOS ONE, →DOI",
          "text": "More recently, other biological drugs, such as ustekinumab, ixekizumab, tofacitinib, secukinumab and briakinumab, have targeted immunological mediators of the disease.",
          "type": "quotation"
        }
      ],
      "glosses": [
        "A humanized monoclonal antibody for the treatment of autoimmune diseases. It works by binding to interleukin 17 and blocking its action."
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "humanized",
          "humanized"
        ],
        [
          "monoclonal antibody",
          "monoclonal antibody"
        ],
        [
          "autoimmune",
          "autoimmune"
        ],
        [
          "disease",
          "disease"
        ],
        [
          "interleukin",
          "interleukin"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A humanized monoclonal antibody for the treatment of autoimmune diseases. It works by binding to interleukin 17 and blocking its action."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "ixekizumab"
      ]
    }
  ],
  "word": "ixekizumab"
}

This page is a part of the kaikki.org machine-readable All languages combined dictionary. This dictionary is based on structured data extracted on 2024-05-24 from the enwiktionary dump dated 2024-05-02 using wiktextract (46b31b8 and c7ea76d). The data shown on this site has been post-processed and various details (e.g., extra categories) removed, some information disambiguated, and additional data merged from other sources. See the raw data download page for the unprocessed wiktextract data.

If you use this data in academic research, please cite Tatu Ylonen: Wiktextract: Wiktionary as Machine-Readable Structured Data, Proceedings of the 13th Conference on Language Resources and Evaluation (LREC), pp. 1317-1325, Marseille, 20-25 June 2022. Linking to the relevant page(s) under https://kaikki.org would also be greatly appreciated.